Pharmacokinetics of Bevacizumab in Three Patients Under the Age of 3 Years with CNS Malignancies
Crossref DOI link: https://doi.org/10.1007/s40268-017-0190-z
Published Online: 2017-06-02
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gojo, Johannes
Sauermann, Robert
Knaack, Ursula
Slavc, Irene
Peyrl, Andreas http://orcid.org/0000-0002-5736-8231
Funding for this research was provided by:
Forschungsgesellschaft für cerebrale Tumore
License valid from 2017-06-02